ROUNDTABLE Failure to Launch MSCs 10 years later: What's on the Horizon?
Wednesday, May 31, 2023 01:00 PM - 02:00 PM
Room 241
Clinic & the Lab
Roundtable
Is there a future for MSCs? What is the path forward for these therapies?
Moderators
Yufang Shi, PhD, Director/Professor, Soochow University Institutes for Translational Medicine, China
Jacques Galipeau, MD, FRCP (C), Associate Dean for Therapeutics Development, University of Wisconsin-Madison, USA
Panelists
Ivan Martin, PhD, Head of Department of Biomedicine, University of Basel, Switzerland
Sowmya Viswanathan, PhD, Scientist at the Osteoarthritis Program/Associate Professor at the Institute of Biomedical Engineering and Department of Medicine, University Health Network, Canada
Michael Schuster, MS, MBA, Head of Business Development and Project Management, Mesoblast, USA
Learning Objectives
Moderators
Yufang Shi, PhD, Director/Professor, Soochow University Institutes for Translational Medicine, China
Jacques Galipeau, MD, FRCP (C), Associate Dean for Therapeutics Development, University of Wisconsin-Madison, USA
Panelists
Ivan Martin, PhD, Head of Department of Biomedicine, University of Basel, Switzerland
Sowmya Viswanathan, PhD, Scientist at the Osteoarthritis Program/Associate Professor at the Institute of Biomedical Engineering and Department of Medicine, University Health Network, Canada
Michael Schuster, MS, MBA, Head of Business Development and Project Management, Mesoblast, USA
Learning Objectives
- By bringing together experts from different fields, the roundtable discussion is expected to identify the main challenges and limitations of MSC therapy in clinical trials;
- By providing a platform for the participants to brainstorm and propose potential solutions and strategies, the roundtable discussion will explore potential solutions and strategies to optimize MSC therapy in clinical trials;
- By serving as a means of fostering collaboration and communication among different stakeholders in MSC therapy, the roundtable discussion will bring together academic researchers, industry partners, clinicians, patients, and regulators to establish common goals and priorities, share best practices and resources, and promote transparency and accountability.
Jacques Galipeau MD, FRCP (C)
Associate Dean for Therapeutics Development
University of Wisconsin in Madision
Moderator
Associate Dean for Therapeutics Development
University of Wisconsin in Madision
Moderator
Yufang Shi PhD
Director/Professor
Soochow University Institutes for Translational Medicine
Moderator
Director/Professor
Soochow University Institutes for Translational Medicine
Moderator
Sowmya Viswanathan PhD
Scientist at the Osteoarthritis Program/Associate Professor at the Institute of Biomedical Engineering and Department of Medicine
University Health Network
Panelist
Scientist at the Osteoarthritis Program/Associate Professor at the Institute of Biomedical Engineering and Department of Medicine
University Health Network
Panelist